Savencia (XPAR:SAVE) Research & Development: €0 Mil (TTM As of Dec. 2025)


XPAR:SAVE Savencia SA XPAR:SAVE
80 GF Score
Price €66.60
GF Value €60.97
Valuation Fairly Valued
! 9 Warning Signs
View Full Analysis

What is Savencia Research & Development?

Savencia XPAR:SAVE 80 Research & Development is €0 Mil as of Dec. 2025. GuruFocus rates XPAR:SAVE with a GF Score™ of 80/100 and a GF Value™ of €60.97 (Fairly Valued). The stock has 9 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Savencia's Research & Development for the six months ended in Dec. 2025 was €0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 was €0 Mil.

Savencia  (XPAR:SAVE) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Savencia Research & Development Related Terms

Savencia Research & Development Historical Data

* Premium members only.

The historical data trend for Savencia's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Savencia Research & Development Chart

Savencia Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Savencia Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
XPAR:SAVE
80GF Score
Savencia SA XPAR:SAVE
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Savencia Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was €0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of €0 Mil mean?
Savencia (XPAR:SAVE) has a Research & Development of €0 Mil as of Dec. 2025. Research and development expense is the total cost for research and development activities. View historical data on Savencia and its competitors.
Is Savencia's Research & Development too high?
Savencia's current Research & Development is €0 Mil. Overall, Savencia has a GF Score™ of 80/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Savencia's Research & Development compare to KHC and GIS?
Savencia's Research & Development of €0 Mil can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Consumer Packaged Goods company?
A good Research & Development depends on the Consumer Packaged Goods industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Savencia and its competitors. Savencia's current Research & Development is €0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Savencia stock overvalued right now?
Based on GuruFocus' analysis, Savencia (XPAR:SAVE) is currently considered Fairly Valued. The stock's GF Value™ is €60.97, compared to a current price of €66.60 — trading 9.2% above its estimated fair value. The current Research & Development is €0 Mil. Savencia's overall GF Score™ is 80/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Savencia (XPAR:SAVE), the current Research & Development is €0 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Savencia (XPAR:SAVE) Overvalued in 2026?

Based on GuruFocus' analysis, Savencia stock appears to be overvalued. The current stock price of €66.60 is trading 9.2% above its estimated GF Value™ of €60.97. GuruFocus considers Savencia to be Fairly Valued.

Key valuation signals for XPAR:SAVE:

  • Research & Development: €0 Mil
  • GF Value™: €60.97 vs. price of €66.60 (9.2% above fair value)
  • GF Score™: 80/100 with 9 warning signs

No single metric tells the full story. See the XPAR:SAVE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Savencia Business Description

Other Exchanges BNGRF:USA0DTK:UKBGJ:Germany
Address 42 rue Rieussec, Viroflay, FRA, 78220
Savencia SA is a producer of high-value-added dairy products. The company produces consumer products such as cheese, butter, and cream for the retail market; food service of technical butter and specific dairy proteins for the food, dietary, and health industries. Its brands are Savencia Fromage & Dairy has a portfolio of Geramont, Saint Albray and Fol Epi, Alouette, Corman, Lescure, Elle & Vire, and others. The company has operations in North America, Western Europe, Central and Eastern Europe, Latin America, Africa and Middle East, and Asia-Pacific. The company generates the majority of its revenue from the sale of Cheese products.
80GF Score

Get the complete analysis for XPAR:SAVE

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€66.60
Price
€60.97
GF Value